FDA Signals Unclear Clinical Benefits Of Ardelyx's Kidney Disease Candidate
November 14, 2022 at 14:20 PM EST
The FDA's Cardiovascular and Renal Drugs Advisory Committee isscheduled to meetWednesday, November 16, to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.